Patrick J. McEnany - 18 Aug 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
18 Aug 2022
Net transactions value
-$3,443,775
Form type
4
Filing time
19 Aug 2022, 17:02:54 UTC
Previous filing
16 Feb 2022
Next filing
15 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $63,250 +25,000 +0.51% $2.53* 4,955,217 18 Aug 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $348,350 -25,000 -0.5% $13.93 4,930,217 18 Aug 2022 Direct F1, F6
transaction CPRX Common stock, par value $0.001 per share Options Exercise $126,500 +50,000 +1% $2.53* 4,980,217 18 Aug 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $696,500 -50,000 -1% $13.93 4,930,217 18 Aug 2022 Direct F2, F6
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $126,500 +50,000 +1% $2.53* 4,980,217 18 Aug 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $697,950 -50,000 -1% $13.96 4,930,217 18 Aug 2022 Direct F3, F6
transaction CPRX Common stock,. par value $0.001 per share Options Exercise $126,500 +50,000 +1% $2.53* 4,980,217 18 Aug 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $697,550 -50,000 -1% $13.95 4,930,217 18 Aug 2022 Direct F4, F6
transaction CPRX Common stock, par value $0.001 per share Options Exercise $316,250 +125,000 +2.5% $2.53* 5,055,217 19 Aug 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $1,762,425 -125,000 -2.5% $14.10 4,930,217 19 Aug 2022 Direct F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -25,000 -0.68% $0.000000 3,640,834 18 Aug 2022 Common Stock 25,000 $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -1.4% $0.000000 3,590,834 18 Aug 2022 Common Stock 50,000 $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -1.4% $0.000000 3,540,834 18 Aug 2022 Common Stock 50,000 $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -1.4% $0.000000 3,490,834 18 Aug 2022 Common Stock 50,000 $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -125,000 -3.6% $0.000000 3,365,834 19 Aug 2022 Common Stock 125,000 $2.53 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold in various lots from $13.93 to $13.97 per share. The listed sales price represents a weighted average price for the shares sold.
F2 Shares were sold in various lots from $13.93 to $13.94 per share. The listed sales price represents a weighted average price for the shares sold.
F3 Shares were sold in various lots from $13.95 to $14.00 per share. The listed sales price represents a weighted average price for the shares sold.
F4 Shares were sold in various lots from $13.95 to $13.98 per share. The listed sales price represents a weighted average price for the shares sold.
F5 Shares were sold in various lots from $14.05 to $14.14 per share. The listed sales price represents a weighted average price for the shares sold.
F6 Shares were sold to cover the exercise price of options, tax withholding requirements (if applicable) and for personal reasons. The shares were not sold as a result of any agreement with the Company and Mr. McEnany remains an officer of the company.
F7 Options vested in three separate tranches beginning on December 30, 2016.